The DOI matches its Crossref record; 84 of the 84 references it cites were found in a registry or an index.
Molecular recognition of morphine and fentanyl by the human μ-opioid receptor
Open accessAbstract
Morphine and fentanyl are among the most used opioid drugs that confer analgesia and unwanted side effects through both G protein and arrestin signaling pathways of μ-opioid receptor (μOR). Here, we report structures of the human μOR-G protein complexes bound to morphine and fentanyl, which uncover key differences in how they bind the receptor. We also report structures of μOR bound to TRV130, PZM21, and SR17018, which reveal preferential interactions of these agonists with TM3 side of the ligand-binding pocket rather than TM6/7 side. In contrast, morphine and fentanyl form dual interactions with both TM3 and TM6/7 regions. Mutations at the TM6/7 interface abolish arrestin recruitment of μOR promoted by morphine and fentanyl. Ligands designed to reduce TM6/7 interactions display preferential G protein signaling. Our results provide crucial insights into fentanyl recognition and signaling of μOR, which may facilitate rational design of next-generation analgesics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
UCSF Chimera—A visualization system for exploratory research and analysis
Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C., & Ferrin, T. E. (2004) · Journal of Computational Chemistry · doi:10.1002/jcc.20084 · Cited by 45,828
Coot : model-building tools for molecular graphics
Emsley, P., & Cowtan, K. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904019158 · Cited by 30,571
PHENIX : a comprehensive Python-based system for macromolecular structure solution
Adams, P. D., Afonine, P. V., Bunkóczi, G., Chen, V. B., Davis, I. W., Echols, N., Headd, J. J., Hung, L.-W., Kapral, G. J., Grosse-Kunstleve, R. W., et al. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909052925 · Cited by 23,716
MolProbity : all-atom structure validation for macromolecular crystallography
Chen, V. B., Arendall, W. B., Headd, J. J., Keedy, D. A., Immormino, R. M., Kapral, G. J., Murray, L. W., Richardson, J. S., & Richardson, D. C. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909042073 · Cited by 14,115
UCSF ChimeraX: Structure visualization for researchers, educators, and developers
Pettersen, E. F., Goddard, T. D., Huang, C. C., Meng, E. C., Couch, G. S., Croll, T. I., Morris, J. H., & Ferrin, T. E. (2021) · Protein Science · doi:10.1002/pro.3943 · Cited by 9,514
MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy
Zheng, S. Q., Palovcak, E., Armache, J.-P., Verba, K. A., Cheng, Y., & Agard, D. A. (2017) · Nature Methods · doi:10.1038/nmeth.4193 · Cited by 7,777
PTRAJ and CPPTRAJ: Software for Processing and Analysis of Molecular Dynamics Trajectory Data
Roe, D. R., & Cheatham, T. E. (2013) · Journal of Chemical Theory and Computation · doi:10.1021/ct400341p · Cited by 7,382
Automated electron microscope tomography using robust prediction of specimen movements
Mastronarde, D. N. (2005) · Journal of Structural Biology · doi:10.1016/j.jsb.2005.07.007 · Cited by 5,336
CTFFIND4: Fast and accurate defocus estimation from electron micrographs
Rohou, A., & Grigorieff, N. (2015) · Journal of Structural Biology · doi:10.1016/j.jsb.2015.08.008 · Cited by 4,913
New tools for automated high-resolution cryo-EM structure determination in RELION-3
Zivanov, J., Nakane, T., Forsberg, B. O., Kimanius, D., Hagen, W. J., Lindahl, E., & Scheres, S. H. (2018) · eLife · doi:10.7554/elife.42166 · Cited by 4,621
Lee, J., Cheng, X., Swails, J. M., Yeom, M. S., Eastman, P. K., Lemkul, J. A., Wei, S., Buckner, J., Jeong, J. C., Qi, Y., et al. (2016) · Journal of Chemical Theory and Computation · doi:10.1021/acs.jctc.5b00935 · Cited by 4,171
Self-citationGctf: Real-time CTF determination and correction
Zhang, K. (2016) · Journal of Structural Biology · doi:10.1016/j.jsb.2015.11.003 · Cited by 3,537
Crystal structure of the β2 adrenergic receptor–Gs protein complex
Rasmussen, S. G. F., DeVree, B. T., Zou, Y., Kruse, A. C., Chung, K. Y., Kobilka, T. S., Thian, F. S., Chae, P. S., Pardon, E., Calinski, D., et al. (2011) · Nature · doi:10.1038/nature10361 · Cited by 3,009
Ballesteros, J. A., & Weinstein, H. (1995) · Methods in Neurosciences · doi:10.1016/s1043-9471(05)80049-7 · Cited by 2,999
CHARMM-GUI Membrane Builder toward realistic biological membrane simulations
Wu, E. L., Cheng, X., Jo, S., Rui, H., Song, K. C., Dávila-Contreras, E. M., Qi, Y., Lee, J., Monje-Galvan, V., Venable, R. M., et al. (2014) · Journal of Computational Chemistry · doi:10.1002/jcc.23702 · Cited by 2,656
Self-citationTian, C., Kasavajhala, K., Belfon, K. A. A., Raguette, L., Huang, H., Migues, A. N., Bickel, J., Wang, Y., Pincay, J., Wu, Q., et al. (2020) · Journal of Chemical Theory and Computation · doi:10.1021/acs.jctc.9b00591 · Cited by 2,503
Self-citationQuantifying the local resolution of cryo-EM density maps
Kucukelbir, A., Sigworth, F. J., & Tagare, H. D. (2014) · Nature Methods · doi:10.1038/nmeth.2727 · Cited by 1,833
Matthes, H. W. D., Maldonado, R., Simonin, F., Valverde, O., Slowe, S., Kitchen, I., Befort, K., Dierich, A., Le Meur, M., Dollé, P., et al. (1996) · Nature · doi:10.1038/383819a0 · Cited by 1,722
Crystal structure of the µ-opioid receptor bound to a morphinan antagonist
Manglik, A., Kruse, A. C., Kobilka, T. S., Thian, F. S., Mathiesen, J. M., Sunahara, R. K., Pardo, L., Weis, W. I., Kobilka, B. K., & Granier, S. (2012) · Nature · doi:10.1038/nature10954 · Cited by 1,356
DeepEMhancer: a deep learning solution for cryo-EM volume post-processing
Sanchez-Garcia, R., Gomez-Blanco, J., Cuervo, A., Carazo, J. M., Sorzano, C. O. S., & Vargas, J. (2021) · Communications Biology · doi:10.1038/s42003-021-02399-1 · Cited by 1,343
Approximate atomic surfaces from linear combinations of pairwise overlaps (LCPO)
Weiser, J., Shenkin, P. S., & Still, W. C. (1999) · Journal of Computational Chemistry · doi:10.1002/(sici)1096-987x(19990130)20:2<217::aid-jcc4>3.0.co;2-a · Cited by 1,198
Enhanced Morphine Analgesia in Mice Lacking β-Arrestin 2
Bohn, L. M., Lefkowitz, R. J., Gainetdinov, R. R., Peppel, K., Caron, M. G., & Lin, F.-T. (1999) · Science · doi:10.1126/science.286.5449.2495 · Cited by 1,077
Molecular mechanisms of opioid receptor-dependent signaling and behavior
Al-Hasani, R., & Bruchas, M. R. (2011) · Anesthesiology · doi:10.1097/aln.0b013e318238bba6 · Cited by 1,067
Mattson, C. L., Tanz, L. J., Quinn, K., Kariisa, M., Patel, P., & Davis, N. L. (2021) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7006a4 · Cited by 1,063
Structure-based discovery of opioid analgesics with reduced side effects
Manglik, A., Lin, H., Aryal, D. K., McCorvy, J. D., Dengler, D., Corder, G., Levit, A., Kling, R. C., Bernat, V., Hübner, H., et al. (2016) · Nature · doi:10.1038/nature19112 · Cited by 944
μ-Opioid receptor desensitization by β-arrestin-2 determines morphine tolerance but not dependence
Bohn, L. M., Gainetdinov, R. R., Lin, F.-T., Lefkowitz, R. J., & Caron, M. G. (2000) · Nature · doi:10.1038/35047086 · Cited by 927
Structural insights into µ-opioid receptor activation
Huang, W., Manglik, A., Venkatakrishnan, A. J., Laeremans, T., Feinberg, E. N., Sanborn, A. L., Kato, H. E., Livingston, K. E., Thorsen, T. S., Kling, R. C., et al. (2015) · Nature · doi:10.1038/nature14886 · Cited by 885
A fast and high-quality charge model for the next generation general AMBER force field
He, X., Man, V. H., Yang, W., Lee, T.-S., & Wang, J. (2020) · The Journal of Chemical Physics · doi:10.1063/5.0019056 · Cited by 783
Self-citationWaldhoer, M., Bartlett, S. E., & Whistler, J. L. (2004) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.73.011303.073940 · Cited by 740
Structure of the δ-opioid receptor bound to naltrindole
Granier, S., Manglik, A., Kruse, A. C., Kobilka, T. S., Thian, F. S., Weis, W. I., & Kobilka, B. K. (2012) · Nature · doi:10.1038/nature11111 · Cited by 667
Structure of the µ-opioid receptor–Gi protein complex
Koehl, A., Hu, H., Maeda, S., Zhang, Y., Qu, Q., Paggi, J. M., Latorraca, N. R., Hilger, D., Dawson, R., Matile, H., et al. (2018) · Nature · doi:10.1038/s41586-018-0219-7 · Cited by 658
DeWire, S. M., Yamashita, D. S., Rominger, D. H., Liu, G., Cowan, C. L., Graczyk, T. M., Chen, X.-T., Pitis, P. M., Gotchev, D., Yuan, C., et al. (2013) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.201616 · Cited by 647
Morphine Side Effects in β-Arrestin 2 Knockout Mice
Raehal, K. M., Walker, J. K. L., & Bohn, L. M. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.087254 · Cited by 626
Bias factor and therapeutic window correlate to predict safer opioid analgesics
Schmid, C. L., Kennedy, N. M., Ross, N. C., Lovell, K. M., Yue, Z., Morgenweck, J., Cameron, M. D., Bannister, T. D., & Bohn, L. M. (2017) · Cell · doi:10.1016/j.cell.2017.10.035 · Cited by 567
A brief history of opiates, opioid peptides, and opioid receptors.
Brownstein, M. J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.12.5391 · Cited by 491
Structure of the nociceptin/orphanin FQ receptor in complex with a peptide mimetic
Thompson, A. A., Liu, W., Chun, E., Katritch, V., Wu, H., Vardy, E., Huang, X.-P., Trapella, C., Guerrini, R., Calo, G., et al. (2012) · Nature · doi:10.1038/nature11085 · Cited by 477
Self-citationCHARMM-GUI supports the Amber force fields
Lee, J., Hitzenberger, M., Rieger, M., Kern, N. R., Zacharias, M., & Im, W. (2020) · The Journal of Chemical Physics · doi:10.1063/5.0012280 · Cited by 428
MDpocket: open-source cavity detection and characterization on molecular dynamics trajectories
Schmidtke, P., Bidon-Chanal, A., Luque, F. J., & Barril, X. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr550 · Cited by 395
Clinical Pharmacokinetics of Fentanyl and its Newer Derivatives
Mather, L. E. (1983) · Clinical Pharmacokinetics · doi:10.2165/00003088-198308050-00004 · Cited by 393
CHARMM‐GUI 10 years for biomolecular modeling and simulation
Jo, S., Cheng, X., Lee, J., Kim, S., Park, S., Patel, D. S., Beaven, A. H., Lee, K. I., Rui, H., Park, S., et al. (2017) · Journal of Computational Chemistry · doi:10.1002/jcc.24660 · Cited by 383
Self-citationStructure of the neurotensin receptor 1 in complex with β-arrestin 1
Huang, W., Masureel, M., Qu, Q., Janetzko, J., Inoue, A., Kato, H. E., Robertson, M. J., Nguyen, K. C., Glenn, J. S., Skiniotis, G., et al. (2020) · Nature · doi:10.1038/s41586-020-1953-1 · Cited by 373
Structure of the Nanobody-Stabilized Active State of the Kappa Opioid Receptor
Che, T., Majumdar, S., Zaidi, S. A., Ondachi, P., McCorvy, J. D., Wang, S., Mosier, P. D., Uprety, R., Vardy, E., Krumm, B. E., et al. (2018) · Cell · doi:10.1016/j.cell.2017.12.011 · Cited by 365
Structure of the M2 muscarinic receptor–β-arrestin complex in a lipid nanodisc
Staus, D. P., Hu, H., Robertson, M. J., Kleinhenz, A. L. W., Wingler, L. M., Capel, W. D., Latorraca, N. R., Lefkowitz, R. J., & Skiniotis, G. (2020) · Nature · doi:10.1038/s41586-020-1954-0 · Cited by 351
Gillis, A., Gondin, A. B., Kliewer, A., Sanchez, J., Lim, H. D., Alamein, C., Manandhar, P., Santiago, M., Fritzwanker, S., Schmiedel, F., et al. (2020) · Science Signaling · doi:10.1126/scisignal.aaz3140 · Cited by 336
Molecular basis of β-arrestin coupling to formoterol-bound β1-adrenoceptor
Lee, Y., Warne, T., Nehmé, R., Pandey, S., Dwivedi-Agnihotri, H., Chaturvedi, M., Edwards, P. C., García-Nafría, J., Leslie, A. G. W., Shukla, A. K., et al. (2020) · Nature · doi:10.1038/s41586-020-2419-1 · Cited by 295
Kliewer, A., Schmiedel, F., Sianati, S., Bailey, A., Bateman, J. T., Levitt, E. S., Williams, J. T., Christie, M. J., & Schulz, S. (2019) · Nature Communications · doi:10.1038/s41467-018-08162-1 · Cited by 291
Angiotensin Analogs with Divergent Bias Stabilize Distinct Receptor Conformations
Wingler, L. M., Elgeti, M., Hilger, D., Latorraca, N. R., Lerch, M. T., Staus, D. P., Dror, R. O., Kobilka, B. K., Hubbell, W. L., & Lefkowitz, R. J. (2019) · Cell · doi:10.1016/j.cell.2018.12.005 · Cited by 272
Structural insights into the lipid and ligand regulation of serotonin receptors
Xu, P., Huang, S., Zhang, H., Mao, C., Zhou, X. E., Cheng, X., Simon, I. A., Shen, D.-D., Yen, H.-Y., Robinson, C. V., et al. (2021) · Nature · doi:10.1038/s41586-021-03376-8 · Cited by 270
Self-citationStructural insights into the human D1 and D2 dopamine receptor signaling complexes
Zhuang, Y., Xu, P., Mao, C., Wang, L., Krumm, B., Zhou, X. E., Huang, S., Liu, H., Cheng, X., Huang, X.-P., et al. (2021) · Cell · doi:10.1016/j.cell.2021.01.027 · Cited by 253
Self-citationMorphine‐induced respiratory depression is independent of β‐arrestin2 signalling
Kliewer, A., Gillis, A., Hill, R., Schmiedel, F., Bailey, C., Kelly, E., Henderson, G., Christie, M. J., & Schulz, S. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15004 · Cited by 245
Development of an antibody fragment that stabilizes GPCR/G-protein complexes
Maeda, S., Koehl, A., Matile, H., Hu, H., Hilger, D., Schertler, G. F. X., Manglik, A., Skiniotis, G., Dawson, R. J. P., & Kobilka, B. K. (2018) · Nature Communications · doi:10.1038/s41467-018-06002-w · Cited by 230
Chen, X.-T., Pitis, P., Liu, G., Yuan, C., Gotchev, D., Cowan, C. L., Rominger, D. H., Koblish, M., DeWire, S. M., Crombie, A. L., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm4010829 · Cited by 208
Duan, J., Shen, D.-D., Zhou, X. E., Bi, P., Liu, Q.-F., Tan, Y.-X., Zhuang, Y.-W., Zhang, H.-B., Xu, P.-Y., Huang, S.-J., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17933-8 · Cited by 205
Self-citationSingla, N. K., Skobieranda, F., Soergel, D. G., Salamea, M., Burt, D. A., Demitrack, M. A., & Viscusi, E. R. (2019) · Pain Practice · doi:10.1111/papr.12801 · Cited by 182
Structural determinants of 5-HT2B receptor activation and biased agonism
McCorvy, J. D., Wacker, D., Wang, S., Agegnehu, B., Liu, J., Lansu, K., Tribo, A. R., Olsen, R. H. J., Che, T., Jin, J., et al. (2018) · Nature Structural & Molecular Biology · doi:10.1038/s41594-018-0116-7 · Cited by 171
Self-citationViscusi, E. R., Skobieranda, F., Soergel, D. G., Cook, E., Burt, D. A., & Singla, N. (2019) · Journal of Pain Research · doi:10.2147/jpr.s171013 · Cited by 167
Altarifi, A. A., David, B., Muchhala, K. H., Blough, B. E., Akbarali, H., & Negus, S. S. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881116689257 · Cited by 166
Hill, R., Disney, A., Conibear, A., Sutcliffe, K., Dewey, W., Husbands, S., Bailey, C., Kelly, E., & Henderson, G. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14224 · Cited by 165
Levitt, E. S., Abdala, A. P., Paton, J. F. R., Bissonnette, J. M., & Williams, J. T. (2015) · The Journal of Physiology · doi:10.1113/jp270822 · Cited by 142
The anomalous pharmacology of fentanyl
Kelly, E., Sutcliffe, K. J., Cavallo, D., Ramos‐Gonzalez, N., Alhosan, N., & Henderson, G. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15573 · Cited by 138
G-protein–gated Inwardly Rectifying Potassium Channels Modulate Respiratory Depression by Opioids
Montandon, G., Ren, J. T., Victoria, N. C., Liu, H., Wickman, K., Greer, J. J., & Horner, R. L. (2015) · Anesthesiology · doi:10.1097/aln.0000000000000984 · Cited by 135
Elucidating the active δ-opioid receptor crystal structure with peptide and small-molecule agonists
Claff, T., Yu, J., Blais, V., Patel, N., Martin, C., Wu, L., Han, G. W., Holleran, B. J., der Poorten, O. V., White, K. L., et al. (2019) · Science Advances · doi:10.1126/sciadv.aax9115 · Cited by 131
Biased ligands at opioid receptors: Current status and future directions
Che, T., Dwivedi‐Agnihotri, H., Shukla, A. K., & Roth, B. L. (2021) · Science Signaling · doi:10.1126/scisignal.aav0320 · Cited by 131
How μ-opioid receptor recognizes fentanyl
Vo, Q. N., Mahinthichaichan, P., Shen, J., & Ellis, C. R. (2021) · Nature Communications · doi:10.1038/s41467-021-21262-9 · Cited by 127
Self-citationFatalities Involving Carfentanil and Furanyl Fentanyl: Two Case Reports
Swanson, D. M., Hair, L. S., Rivers, S. R. S., Smyth, B. C., Brogan, S. C., Ventoso, A. D., Vaccaro, S. L., & Pearson, J. M. (2017) · Journal of Analytical Toxicology · doi:10.1093/jat/bkx037 · Cited by 116
Zhuang, Y., Liu, H., Zhou, X. E., Verma, R. K., de Waal, P. W., Jang, W., Xu, T.-H., Wang, L., Meng, X. M., Zhao, G., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-14728-9 · Cited by 112
Self-citationDARK Classics in Chemical Neuroscience: Fentanyl
Burns, M., Cunningham, C. W., & Mercer, S. L. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00174 · Cited by 106
Ligand recognition and G-protein coupling selectivity of cholecystokinin A receptor
Liu, Q., Yang, D., Zhuang, Y., Croll, T. I., Cai, X., Dai, A., He, X., Duan, J., Yin, W., Ye, C., et al. (2021) · Nature Chemical Biology · doi:10.1038/s41589-021-00841-3 · Cited by 104
Self-citationIdentification and mechanism of G protein-biased ligands for chemokine receptor CCR1
Shao, Z., Shen, Q., Yao, B., Mao, C., Chen, L.-N., Zhang, H., Shen, D., Zhang, C., Li, W., Du, X., et al. (2021) · Nature Chemical Biology · doi:10.1038/s41589-021-00918-z · Cited by 90
Self-citationMolecular insights into the biased signaling mechanism of the μ-opioid receptor
Cong, X., Maurel, D., Déméné, H., Vasiliauskaité-Brooks, I., Hagelberger, J., Peysson, F., Saint‐Paul, J., Golebiowski, J., Granier, S., & Sounier, R. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.07.033 · Cited by 89
Structural basis of sphingosine-1-phosphate receptor 1 activation and biased agonism
Xu, Z., Ikuta, T., Kawakami, K., Kise, R., Qian, Y., Xia, R., Sun, M.-X., Zhang, A., Guo, C., Cai, X.-H., et al. (2021) · Nature Chemical Biology · doi:10.1038/s41589-021-00930-3 · Cited by 87
Novel Opioid Analgesics and Side Effects
Vecchio, G. D., Spahn, V., & Stein, C. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00195 · Cited by 82
Designing Safer Analgesics via μ-Opioid Receptor Pathways
Chan, H. C. S., McCarthy, D. R., Li, J., Palczewski, K., & Yuan, S. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.08.004 · Cited by 81
Stabilization of G protein-coupled receptors by point mutations
Heydenreich, F. M., Vuckovic, Z., Matkovic, M., & Veprintsev, D. B. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00082 · Cited by 80
Molecular dynamics of fentanyl bound to μ-opioid receptor
Lipiński, P. F. J., Jarończyk, M., Dobrowolski, J. C., & Sadlej, J. (2019) · Journal of Molecular Modeling · doi:10.1007/s00894-019-3999-2 · Cited by 79
Ricarte, A., Dalton, J. A. R., & Giraldo, J. (2021) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.0c00890 · Cited by 79
Structure‐Based Evolution of G Protein‐Biased μ‐Opioid Receptor Agonists
Wang, H., Hetzer, F., Huang, W., Qu, Q., Meyerowitz, J., Kaindl, J. M., Hübner, H., Skiniotis, G., Kobilka, B. K., & Gmeiner, P. (2022) · Angewandte Chemie International Edition · doi:10.1002/anie.202200269 · Cited by 75
The structural basis of the dominant negative phenotype of the Gαi1β1γ2 G203A/A326S heterotrimer
Liu, P., Jia, M.-Z., Zhou, X. E., de Waal, P. W., Dickson, B. M., Liu, B., Hou, L., Yin, Y., Kang, Y., Shi, Y., et al. (2016) · Acta Pharmacologica Sinica · doi:10.1038/aps.2016.69 · Cited by 72
Self-citationAminergic GPCR–Ligand Interactions: A Chemical and Structural Map of Receptor Mutation Data
Vass, M., Podlewska, S., de Esch, I. J. P., Bojarski, A. J., Leurs, R., Kooistra, A. J., & de Graaf, C. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00836 · Cited by 72
Molecular Basis of Opioid Action: From Structures to New Leads
Manglik, A. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2019.08.028 · Cited by 66
Eshleman, A. J., Nagarajan, S., Wolfrum, K. M., Reed, J. F., Nilsen, A., Torralva, R., & Janowsky, A. J. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114293 · Cited by 64
Molecular mechanisms of fentanyl mediated β-arrestin biased signaling
de Waal, P. W., Shi, J., You, E., Wang, X., Melcher, K., Jiang, Y., Xu, H. E., & Dickson, B. M. (2020) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1007394 · Cited by 62
Self-citationResidues W320 and Y328 within the binding site of the μ-opioid receptor influence opiate ligand bias
Hothersall, J. D., Torella, R., Humphreys, S., Hooley, M., Brown, A., McMurray, G., & Nickolls, S. A. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.03.007 · Cited by 43
DARK Classics in Chemical Neuroscience: Carfentanil
Ringuette, A. E., Spock, M., Lindsley, C. W., & Bender, A. M. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00441 · Cited by 28
Cited by
G protein-coupled receptors (GPCRs): advances in structures, mechanisms and drug discovery
Zhang, M., Chen, T., Lu, X., Lan, X., Chen, Z., & Lu, S. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01803-6 · Cited by 491
Glatfelter, G. C., Vandeputte, M. M., Chen, L., Walther, D., Tsai, M.-H. M., Shi, L., Stove, C. P., & Baumann, M. H. (2023) · Psychopharmacology · doi:10.1007/s00213-023-06451-2 · Cited by 52
Vandeputte, M. M., Tsai, M.-H. M., Chen, L., Glatfelter, G. C., Walther, D., Stove, C. P., Shi, L., & Baumann, M. H. (2023) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2023.109939 · Cited by 39
Luo, M.-L., Zhao, Q., He, X.-H., Xie, X., Zhu, H.-P., You, F.-M., Peng, C., Zhan, G., & Huang, W. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114574 · Cited by 25
Self-citationRetractedAlhosan, N., Cavallo, D., Santiago, M., Kelly, E., & Henderson, G. (2025) · British Journal of Pharmacology · doi:10.1111/bph.17376 · Cited by 23
Metadata
- Authors
- Zhuang, Y., Wang, Y., He, B., He, X., Zhou, X. E., Guo, S., Rao, Q., Yang, J., Liu, J., Zhou, Q., Wang, X., Liu, M., Liu, W., Jiang, X., Yang, D., Jiang, H., Shen, J., Melcher, K., Chen, H., Jiang, Y., Cheng, X., Wang, M.-W., Xie, X., & Xu, H. E.
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2022-11
- Volume
- 185
- Issue
- 23
- Pages
- 4361-4375.e19
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W4309042619
- Cited by
- 273
- References
- 84
- FWCI
- 14.57
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.